The New York Times, August 20, 2024: Ever wonder why there are so many ineffective and unsafe implants and diagnostic tests and other medical devices harming patients? This NYT investigation explains how FDA official Jeff Shuren was involved in decisions that benefited his wife — who worked for Theranos and other major device companies. Why did FDA allow that to happen year after year?
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Jeff Shuren stabilized the FDA’s medical devices center, winning over industry but not all patients
STAT News, August 6, 2024: STAT News article on Jeff Shuren leaving the FDA quotes praise from industry and concerns from physicians, researchers, patients, and public health experts who criticize how many devices are not proven to work.
Read More »How Good Is Wegovy’s Heart Benefit? — Experts put SELECT trial findings in context
MedPage Today, August 1, 2024: When the company that makes Wegovy weight loss drugs say it reduces major cardiovascular events by 20% they really mean it reduces that risk by 1.5% for each patient. That’s because only 8% of the placebo group had major cardiovascular events, compared to 6.5% of the Wegovy patients. Isn’t that misleading? We explain why most weight loss patients will not benefit in terms of heart disease, because the benefit is small and requires staying on Wegovy for almost 3 years.
Read More »Open Letter to the FDA: You’re Protecting the Wrong People
MedShadow, July 23, 2024: We agree with Medshadow that it is outrageous that the FDA is warning companies about fraudulent tests that mean their medications may not be safe or effective but are not warning patients who are buying these medications.
Read More »Revolving door: You are free to influence us “behind the scenes,” FDA tells staff leaving for industry jobs
BMJ, July 1, 2024: BMJ investigation reveals how revolving door and FDA Ethics office allow former FDA staff to lobby for industry and Dr. Diana Zuckerman explains how this creates conflicts of interest that undermine FDA decision-making.
Read More »